DHR insider trading
NYSE HealthcareDANAHER CORP /DE/ — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About DANAHER CORP /DE/
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.
Company website: www.danaher.com
DHR insider activity at a glance
FilingIQ has scored 1,355 insider transactions for DHR since Jan 9, 2015. The most recent filing in our index is dated May 1, 2026.
Across the full history, 18 open-market purchases
and 387 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on DHR insider trades is 67.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest DHR Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading DHR
13F funds holding DHR
Politicians who have traded DHR
Frequently asked
- How many insider trades does FilingIQ track for DHR?
- FilingIQ tracks 1,355 Form 4 insider transactions for DHR (DANAHER CORP /DE/), covering filings from Jan 9, 2015 onwards. 49 of those were filed in the last 90 days.
- Are DHR insiders net buyers or net sellers?
- Across the full Form 4 history for DHR, 18 transactions (1%) were open-market purchases and 387 (29%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does DHR insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is DHR in?
- DANAHER CORP /DE/ (DHR) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $149.76B.
Methodology & sources
Every DHR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.